Dextromethorphan/Guaifenesin/Phenylephrine

右美沙芬/愈创甘油醚/去氧肾上腺素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDextromethorphan/Guaifenesin/Phenylephrine

Drug Alias NameGuaifenesin/phenylephrine/dextrometorphanguaifenesin, phenylephrine and dextrometorphandextromethorphan, guaifenesin, and phenylephrineTusso-XR

ClassificationSmall molecules

Mechanisms of ActionAdrenergic receptor alpha-1 agonistsGlutamate [NMDA] receptor antagonists

TargetsGlutamate [NMDA] receptorAdrenergic receptors alpha-1

Therapy Area/IndicationsCoughNasal Obstruction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Phenylephrine Hydrochloride Guaifenesin Dextromethorphan Hydrobromide

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesEverett Labs

China Registration ClassN/A

Develop Information

Active CompaniesEverett Labs

Inactive CompaniesN/A

Active IndicationsCoughNasal Obstruction

Inactive IndicationsN/A

Other Information

ATC CodeN07XX59R01BA53S01GA55